Haematological cancer versus solid tumour end-of-life care: a longitudinal data analysis.

So-Young YangSun-Kyeong ParkHye-Rim KangHye-Lin KimEui-Kyung LeeSun-Hong Kwon

Published in: BMJ supportive & palliative care (2020)

Patients with haematological malignancies are at a higher risk for aggressive care and economic burden at the end of life compared with those with solid tumours. Detailed attention is required when developing care plans for end-of-life care of haematological patients.

Keyphrases

data analysis
healthcare
end stage renal disease
palliative care
quality improvement
chronic kidney disease
newly diagnosed
ejection fraction
papillary thyroid
prognostic factors
working memory
pain management
affordable care act
squamous cell carcinoma
health insurance
squamous cell
patient reported